Ackman And Valeant Team Up To Pursue Takeover Of Allergan

Activist hedge fund manager Bill Ackman is bringing his sometimes bare-knuckle expertise at the takeover game to Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) as the highly efficient roll-up company targets Botox wrinkle treatment company Allergan, Inc. (NYSE:AGN) with a takeover offer.

Activist hedge fund with successful track record at "encouraging" boards to make the "right" decisions teams with Valeant to acquire Allergan

The Wall Street Journal is reporting that Ackman’s Pershing Square Capital Management has acquired $4 billion in Allergan, Inc. (NYSE:AGN) stock, making this the fund’s largest investment in its history.

According to a CNBC report, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) approached Allergan nearly one year ago...